David Abrams - Abrams Capital Management
Holding/activity history for Keryx Biopharmaceuticals Inc. (KERX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2018 Q4 | 0 | 0 | Sell 100.00% | 0.82 | |
| 2018 Q3 | 9,108,867 | 0.82 | Reduce 8.45% | 0.08 | $3.40 |
| 2018 Q2 | 9,950,055 | 1.04 | Add 2.38% | 0.02 | $3.76 |
| 2018 Q1 | 9,719,176 | 1.25 | $4.09 | ||
| 2017 Q4 | 9,719,176 | 1.52 | Add 69.94% | 0.63 | $4.65 |
| 2017 Q3 | 5,719,176 | 1.58 | $7.10 | ||
| 2017 Q2 | 5,719,176 | 1.64 | $7.23 | ||
| 2017 Q1 | 5,719,176 | 1.35 | $6.16 | ||
| 2016 Q4 | 5,719,176 | 1.23 | $5.86 | ||
| 2016 Q3 | 5,719,176 | 1.51 | $5.31 | ||
| 2016 Q2 | 5,719,176 | 1.98 | $6.62 | ||
| 2016 Q1 | 5,719,176 | 1.26 | Add 3.99% | 0.05 | $4.67 |
| 2015 Q4 | 5,500,000 | 1.52 | Add 10.00% | 0.14 | $5.05 |
| 2015 Q3 | 5,000,000 | 1.26 | Buy | 1.26 | $3.52 |